IDEX Biometrics Completes Successful Share Capital Increase

Author: Evelyn Baker Updated: 06-17-2025 05:00 AM

Significant Share Capital Increase by IDEX Biometrics ASA

IDEX Biometrics ASA has recently made waves in the financial markets with its impressive share capital increase. This remarkable event follows the company’s announcement outlining a resolution from a recent Extraordinary General Meeting to issue up to 600 million new shares. The offering turned out to be a resounding success, being oversubscribed by eight times, showcasing strong investor confidence in IDEX Biometrics.

Details of the Offering

The subsequent offering culminated in the issuance of 600 million new shares at a nominal price of NOK 0.01 per share. As a result, IDEX Biometrics raised a substantial gross amount of NOK 6 million. This capital injection is a significant advancement for the company, bolstering its financial position and enabling it to continue driving innovation in the biometrics sector.

Registered Capital Increase

The increase in share capital has been officially registered with the Norwegian Register of Business Enterprises, marking a pivotal step in the company's growth trajectory. Following this transaction, the total share capital of IDEX Biometrics stands at NOK 44,316,309.99, divided into 4,431,630,999 shares, each valued at NOK 0.01. This capital structure reflects a solid foundation for ongoing operations and future initiatives.

About IDEX Biometrics ASA

IDEX Biometrics ASA (OSE: IDEX) is at the forefront of biometric technology, renowned for its innovative fingerprint authentication solutions. The company specializes in delivering exceptional security and convenience across various sectors, including payments, access control, and digital identity verification.

Innovative Solutions for Diverse Applications

At IDEX, we utilize patented sensor technologies, integrated circuit designs, and bespoke software solutions to create user-friendly biometric applications. Our products are strategically aimed at enhancing card-based payment systems and digital authentication methods. We have forged partnerships with leading card manufacturers and technology innovators, facilitating the market entry of our cutting-edge solutions.

Commitment to Growth and Innovation

As IDEX Biometrics navigates through this significant capital increase, the company is poised to leverage these financial resources to further amplify its R&D efforts and enhance its market position. The commitment to advancing biometric solutions remains steadfast, with a focus on consistent innovation tailored to meet evolving customer needs.

Contact Information

For further details regarding this announcement or other inquiries, please contact:

Kristian Flaten, CFO
E-mail: ir@idexbiometrics.com
Tel: +47 95092322

Frequently Asked Questions

What is the latest share capital increase by IDEX Biometrics?

The latest capital increase involved the issuance of 600 million new shares, raising NOK 6 million.

How many total shares does IDEX Biometrics have now?

After the capital increase, IDEX Biometrics has a total of 4,431,630,999 shares outstanding.

What was the subscription price per share during the offering?

The subscription price was set at NOK 0.01 per share during the offering.

Who can I contact for more information regarding IDEX Biometrics?

You can contact Kristian Flaten, CFO, via email at ir@idexbiometrics.com or call +47 95092322.

What does IDEX Biometrics specialize in?

IDEX Biometrics specializes in fingerprint biometrics, providing authentication solutions for payments, access control, and digital identity verification.

About The Author

Greetings, I'm 32-year-old author and financial specialist Evelyn Baker. My introduction into the financial industry started with an economics degree and continued with a wealth of experience in wealth management and financial consulting. My great passion over the years has been assisting people and companies in making wise, well-informed decisions to reach their financial objectives.

My goal with writing is to simplify difficult financial ideas into understandable, doable guidance. My goal in writing many books and articles is to make personal finance understandable to everyone, irrespective of their experience or background. I want to give readers the information they need to take charge of their financial futures, from investing and retirement planning to budgeting and saving.

Along with my writing, I lead webinars and workshops where I provide doable advice and methods for achieving financial success. To reach a larger audience, I also frequently contribute to financial blogs and publications. My method is always to offer doable, real-world guidance that can actually improve people's lives.

Aside from my job, I like to cook, travel, and experience other cultures. I work hard to apply my belief in the value of a balanced life to my financial counsel. My goal in working is to encourage and enable people to succeed financially so they may lead the best lives possible.

Contact Evelyn Baker privately here. Or send an email with ATTN: Evelyn Baker as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.